Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
179 results
000486 - Objective and Subjective Sleep Assessments in Patients With Atopic Dermatitis Treated With Dupilumab: Results From DUPISTAD, a Phase 4 Randomized Placebo-Controlled Study
000531 - Autoimmune progesterone dermatitis in two sisters
000587 - Generalized Acute Eosinophilic Folliculitis Induced by Drugs in an Oncology Patient
001168 - Intradermal testing beyond allergy diagnosis: Insights into Gardner-Diamond Syndrome
001476 - Hypersensitivity to endogenous progesterone manifested as fixed drug eruption: a case report
001493 - Allergic contact dermatitis due to acrylates contained in catheter fixation devices catheters
001503 - Urticaria exacerbations in children with chronic urticaria receiving COVID-19 vaccination
001566 - Anaphylaxis to diethyltoluamide (DEET) containing insect repellent
001589 - Prevalence of non-alcoholic steatohepatitis in adult patients with hereditary angioedema due to C1-inhibitor deficiency (HAE-C1INH)
001600 - Allergic contact dermatitis caused by acrylates: two different perspectives on the same issue
001672 - Etoricoxib-Induced DRESS Syndrome
001685 - An unusual reaction to cosmetic
001699 - Occupational contact dermatitis to non latex gloves
100093 - Arcoxia - cause of erythema fixed drug
100147 - Flare up by diethylthiurea/dibutylthiourea
100166 - Contact urticaria with phenoxyethanol
100209 - Reliability of UCT and DLQI Questionnaires for Urticaria in the Republic of Kazakhstan
100541 - Systematic evaluation of ChatGPT`s performance on 40 dermatological allergology questions with clinical error impact assessment for erroneous AI-guided chatbot-advice
D1.123 - Inhibition of the Interleukin Cytokines using novel Peptide Inhibitors for Allergy and Asthma Treatment
D1.128 - Dupilumab in a Child with Severe Allergic Asthma, Atopic Dermatitis, Vernal Keratoconjunctivitis, and Partial IgA Deficiency
Pagination
First page
First
Previous page
Previous
Page
1
Page
2
Page
3
Current page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download